AACR 2017: Durability of CAR T cell therapy response may depend on pretreatment disease burden in leukaemia patients

Although most patients with relapsed B-cell acute lymphoblastic leukaemia (B-ALL) experienced complete response after treatment with a type of CAR T-cell immunotherapy, pretreatment disease burden impacted the durability of the responses and longterm...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2nPYAK1
via IFTTT